• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Correspondence on Letter regarding "Waiting for the changes after the adoption of steatotic liver disease".

作者信息

Yoon Eileen L, Jun Dae Won

机构信息

Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea.

Hanyang Institute of Bioscience and Biotechnology, Hanyang University, Seoul, Korea.

出版信息

Clin Mol Hepatol. 2024 Jan;30(1):126-128. doi: 10.3350/cmh.2023.0500. Epub 2023 Nov 28.

DOI:10.3350/cmh.2023.0500
PMID:38016440
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10776294/
Abstract
摘要

相似文献

1
Correspondence on Letter regarding "Waiting for the changes after the adoption of steatotic liver disease".关于“等待脂肪性肝病采用后的变化”信件的通信
Clin Mol Hepatol. 2024 Jan;30(1):126-128. doi: 10.3350/cmh.2023.0500. Epub 2023 Nov 28.
2
Letter regarding "Waiting for the changes after the adoption of steatotic liver disease".关于“等待脂肪性肝病采用后的变化”的信件
Clin Mol Hepatol. 2024 Jan;30(1):118-120. doi: 10.3350/cmh.2023.0472. Epub 2023 Nov 14.
3
[Effect of the nomenclature of non-alcoholic fatty liver disease on diagnosis and treatment of fatty liver disease concomitant with other liver diseases].[非酒精性脂肪性肝病命名对合并其他肝脏疾病的脂肪性肝病诊疗的影响]
Zhonghua Gan Zang Bing Za Zhi. 2023 Aug 20;31(8):805-809. doi: 10.3760/cma.j.cn501113-20230810-0050.
4
Steatotic hepatocellular carcinoma: Association of MRI findings to underlying liver disease and clinicopathological characteristics.脂肪性肝细胞癌：MRI 表现与基础肝病及临床病理特征的相关性。
Liver Int. 2023 Jun;43(6):1332-1344. doi: 10.1111/liv.15589. Epub 2023 Apr 23.
5
Phosphatase and tensin homolog is a differential diagnostic marker between nonalcoholic and alcoholic fatty liver disease.磷酸酶和张力蛋白同源物是非酒精性和酒精性脂肪性肝病之间的鉴别诊断标志物。
World J Gastroenterol. 2016 Apr 14;22(14):3735-45. doi: 10.3748/wjg.v22.i14.3735.
6
Mechanisms of Lipid Droplet Accumulation in Steatotic Liver Diseases.脂肪变性肝疾病中脂滴蓄积的机制。
Semin Liver Dis. 2023 Nov;43(4):367-382. doi: 10.1055/a-2186-3557. Epub 2023 Oct 5.
7
Hepatic Gene Expression Profiles Differentiate Steatotic and Non-steatotic Grafts in Liver Transplant Recipients.肝脏基因表达谱可区分肝移植受者中的脂肪变性和非脂肪变性移植物。
Front Endocrinol (Lausanne). 2019 Apr 30;10:270. doi: 10.3389/fendo.2019.00270. eCollection 2019.
8
[Discussion from metabolism to fatty liver disease: rethinking the origin of disease and the endpoint of new drugs or metabolic dysfunction-associated steatotic liver disease].[从代谢到脂肪性肝病的探讨：重新思考疾病起源及新药终点或代谢功能障碍相关脂肪性肝病]
Zhonghua Gan Zang Bing Za Zhi. 2023 Aug 20;31(8):785-788. doi: 10.3760/cma.j.cn501113-20230815-00057.
9
From non-alcoholic fatty liver disease (NAFLD) to steatotic liver disease (SLD): an ongoing journey towards refining the terminology for this prevalent metabolic condition and unmet clinical need.从非酒精性脂肪性肝病（NAFLD）到脂肪性肝病（SLD）：为这种普遍的代谢状况和未满足的临床需求完善术语的持续进程。
Metabolism. 2023 Oct;147:155664. doi: 10.1016/j.metabol.2023.155664. Epub 2023 Jul 28.
10
Ischemia–reperfusion injury in patients with fatty liver and the clinical impact of steatotic liver on hepatic surgery.脂肪肝患者的缺血-再灌注损伤及脂肪变性肝脏对肝脏手术的临床影响。
Surg Today. 2014 Sep;44(9):1611-25. doi: 10.1007/s00595-013-0736-9.

本文引用的文献

1
Metabolic dysfunction-associated steatotic liver disease increases the risk of incident cardiovascular disease: a nationwide cohort study.代谢功能障碍相关脂肪性肝病增加心血管疾病发病风险：一项全国性队列研究
EClinicalMedicine. 2023 Oct 28;65:102292. doi: 10.1016/j.eclinm.2023.102292. eCollection 2023 Nov.
2
Metabolic dysfunction-associated steatotic liver disease and risk of cardiovascular disease.代谢相关脂肪性肝病与心血管疾病风险。
Gut. 2024 Feb 23;73(3):533-540. doi: 10.1136/gutjnl-2023-331003.
3
A survey on the awareness, current management, and barriers for non-alcoholic fatty liver disease among the general Korean population.一项针对韩国普通人群对非酒精性脂肪性肝病的认知、当前管理和障碍的调查。
Sci Rep. 2023 Sep 14;13(1):15205. doi: 10.1038/s41598-023-42176-0.
4
Waiting for the changes after the adoption of steatotic liver disease.等待肝脂肪变性疾病采用后的变化。
Clin Mol Hepatol. 2023 Oct;29(4):844-850. doi: 10.3350/cmh.2023.0291. Epub 2023 Sep 6.
5
The intersection between alcohol-related liver disease and nonalcoholic fatty liver disease.酒精性肝病与非酒精性脂肪性肝病的交集。
Nat Rev Gastroenterol Hepatol. 2023 Dec;20(12):764-783. doi: 10.1038/s41575-023-00822-y. Epub 2023 Aug 15.
6
Changing the nomenclature from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease is more than a change in terminology.将术语从非酒精性脂肪性肝病改为代谢功能障碍相关脂肪性肝病，这不仅仅是术语的改变。
Clin Mol Hepatol. 2023 Apr;29(2):371-373. doi: 10.3350/cmh.2023.0086. Epub 2023 Mar 14.
7
NAFLD: genetics and its clinical implications.非酒精性脂肪性肝病：遗传学及其临床意义。
Clin Res Hepatol Gastroenterol. 2022 Nov;46(9):102003. doi: 10.1016/j.clinre.2022.102003. Epub 2022 Aug 11.
8
Effects of Moderate Alcohol Drinking in Patients with Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病患者适度饮酒的影响。
Gut Liver. 2019 May 15;13(3):308-314. doi: 10.5009/gnl18175.